Episode 274: Advancing Cancer Immunotherapy with Dr. Besim Ogretmen of Lipo‑Immuno Tech & MUSC

Episode 274: Advancing Cancer Immunotherapy with Dr. Besim Ogretmen of Lipo‑Immuno Tech & MUSC

From Taking the Pulse: a Health Care and Life Sciences Podcast by Taking The Pulse

April 21, 2026 · 16 min

About this episode

Dr. Besim Ogretmen discusses advancements in cancer immunotherapy and the development of novel treatments at the 2026 SCbio Annual Conference.

Recorded at the 2026 SCbio Annual Conference in Charleston, Heather and Matthew are joined by Dr. Besim Ogretmen, an internationally recognized cancer researcher at MUSC and Co-Founder and CEO of Lipo‑Immuno Tech. Dr. Ogretmen shares how his team is developing novel chemoimmunotherapy approaches designed to enhance immune cell function and improve outcomes for patients with advanced cancers. We also discussed building a biotech company from academic research, securing non‑dilutive funding, scaling manufacturing, and leveraging AI to support research and regulatory efforts. Tune in for an inside look at how their unique treatments are changing and extending patients’ lives!

People in this episode

Hosts: Heather, Matthew

Guest: Dr. Besim Ogretmen

Topics covered

  • cancer immunotherapy
  • biotech
  • chemoimmunotherapy
  • AI in research
  • patient outcomes

Keywords

  • cancer
  • immunotherapy
  • biotech
  • AI
  • patient outcomes
  • chemoimmunotherapy
  • funding

Mentioned in this episode

Organizations: Lipo‑Immuno Tech, MUSC

More episodes of Taking the Pulse: a Health Care and Life Sciences Podcast

Explore listener stats, chart rankings, contacts and more on the Taking the Pulse: a Health Care and Life Sciences Podcast podcast page.